Despite RA pre-treatment, inflammatory cytokines led to a persistent population of pro-inflammatory monocytes (CD14+CD16+), which are commonly associated with inflammatory responses in diseases such as IBD (Figure 10). Here, CD14 is linked to inflammatory bowel disease.